Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development.
Identifieur interne : 000C11 ( PubMed/Corpus ); précédent : 000C10; suivant : 000C12Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development.
Auteurs : Oi-Wing Ng ; Yee-Joo TanSource :
- Human vaccines & immunotherapeutics [ 2164-554X ] ; 2017.
English descriptors
- KwdEn :
- Animals, Chiroptera (virology), Disease Outbreaks, High-Throughput Nucleotide Sequencing, Humans, Reverse Genetics, SARS Virus (genetics), SARS Virus (immunology), SARS Virus (isolation & purification), SARS Virus (pathogenicity), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (virology), Viral Vaccines (immunology), Viral Vaccines (isolation & purification).
- MESH :
- chemical , immunology : Viral Vaccines.
- epidemiology : Severe Acute Respiratory Syndrome.
- genetics : SARS Virus.
- immunology : SARS Virus.
- isolation & purification : SARS Virus, Viral Vaccines.
- pathogenicity : SARS Virus.
- virology : Chiroptera, Severe Acute Respiratory Syndrome.
- Animals, Disease Outbreaks, High-Throughput Nucleotide Sequencing, Humans, Reverse Genetics.
Abstract
The severe acute respiratory syndrome coronavirus (SARS-CoV) first emerged in 2003, causing the SARS epidemic which resulted in a 10% fatality rate. The advancements in metagenomic techniques have allowed the identification of SARS-like coronaviruses (SL-CoVs) sequences that share high homology to the human SARS-CoV epidemic strains from wildlife bats, presenting concrete evidence that bats are the origin and natural reservoir of SARS-CoV. The application of reverse genetics further enabled that characterization of these bat CoVs and the prediction of their potential to cause disease in humans. The knowledge gained from such studies is valuable in the surveillance and preparation of a possible future outbreak caused by a spill-over of these bat SL-CoVs.
DOI: 10.1080/21645515.2016.1228500
PubMed: 27644155
Links to Exploration step
pubmed:27644155Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development.</title><author><name sortKey="Ng, Oi Wing" sort="Ng, Oi Wing" uniqKey="Ng O" first="Oi-Wing" last="Ng">Oi-Wing Ng</name><affiliation><nlm:affiliation>a Department of Microbiology and Immunology , Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore , Singapore.</nlm:affiliation></affiliation></author><author><name sortKey="Tan, Yee Joo" sort="Tan, Yee Joo" uniqKey="Tan Y" first="Yee-Joo" last="Tan">Yee-Joo Tan</name><affiliation><nlm:affiliation>a Department of Microbiology and Immunology , Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore , Singapore.</nlm:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:27644155</idno><idno type="pmid">27644155</idno><idno type="doi">10.1080/21645515.2016.1228500</idno><idno type="wicri:Area/PubMed/Corpus">000C11</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000C11</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development.</title><author><name sortKey="Ng, Oi Wing" sort="Ng, Oi Wing" uniqKey="Ng O" first="Oi-Wing" last="Ng">Oi-Wing Ng</name><affiliation><nlm:affiliation>a Department of Microbiology and Immunology , Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore , Singapore.</nlm:affiliation></affiliation></author><author><name sortKey="Tan, Yee Joo" sort="Tan, Yee Joo" uniqKey="Tan Y" first="Yee-Joo" last="Tan">Yee-Joo Tan</name><affiliation><nlm:affiliation>a Department of Microbiology and Immunology , Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore , Singapore.</nlm:affiliation></affiliation></author></analytic><series><title level="j">Human vaccines & immunotherapeutics</title><idno type="eISSN">2164-554X</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term><term>Chiroptera (virology)</term><term>Disease Outbreaks</term><term>High-Throughput Nucleotide Sequencing</term><term>Humans</term><term>Reverse Genetics</term><term>SARS Virus (genetics)</term><term>SARS Virus (immunology)</term><term>SARS Virus (isolation & purification)</term><term>SARS Virus (pathogenicity)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Viral Vaccines (immunology)</term><term>Viral Vaccines (isolation & purification)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Viral Vaccines</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term><term>Viral Vaccines</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Chiroptera</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Disease Outbreaks</term><term>High-Throughput Nucleotide Sequencing</term><term>Humans</term><term>Reverse Genetics</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The severe acute respiratory syndrome coronavirus (SARS-CoV) first emerged in 2003, causing the SARS epidemic which resulted in a 10% fatality rate. The advancements in metagenomic techniques have allowed the identification of SARS-like coronaviruses (SL-CoVs) sequences that share high homology to the human SARS-CoV epidemic strains from wildlife bats, presenting concrete evidence that bats are the origin and natural reservoir of SARS-CoV. The application of reverse genetics further enabled that characterization of these bat CoVs and the prediction of their potential to cause disease in humans. The knowledge gained from such studies is valuable in the surveillance and preparation of a possible future outbreak caused by a spill-over of these bat SL-CoVs.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27644155</PMID><DateCompleted><Year>2017</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2164-554X</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>1</Issue><PubDate><Year>2017</Year><Month>01</Month><Day>02</Day></PubDate></JournalIssue><Title>Human vaccines & immunotherapeutics</Title><ISOAbbreviation>Hum Vaccin Immunother</ISOAbbreviation></Journal><ArticleTitle>Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development.</ArticleTitle><Pagination><MedlinePgn>186-189</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/21645515.2016.1228500</ELocationID><Abstract><AbstractText>The severe acute respiratory syndrome coronavirus (SARS-CoV) first emerged in 2003, causing the SARS epidemic which resulted in a 10% fatality rate. The advancements in metagenomic techniques have allowed the identification of SARS-like coronaviruses (SL-CoVs) sequences that share high homology to the human SARS-CoV epidemic strains from wildlife bats, presenting concrete evidence that bats are the origin and natural reservoir of SARS-CoV. The application of reverse genetics further enabled that characterization of these bat CoVs and the prediction of their potential to cause disease in humans. The knowledge gained from such studies is valuable in the surveillance and preparation of a possible future outbreak caused by a spill-over of these bat SL-CoVs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Oi-Wing</ForeName><Initials>OW</Initials><AffiliationInfo><Affiliation>a Department of Microbiology and Immunology , Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore , Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Yee-Joo</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>a Department of Microbiology and Immunology , Yong Loo Lin School of Medicine, National University Health System (NUHS), National University of Singapore , Singapore.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>b Institute of Molecular and Cell Biology, A*STAR (Agency for Science, Technology and Research) , Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2016</Year><Month>09</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Hum Vaccin Immunother</MedlineTA><NlmUniqueID>101572652</NlmUniqueID><ISSNLinking>2164-5515</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002685" MajorTopicYN="N">Chiroptera</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059014" MajorTopicYN="N">High-Throughput Nucleotide Sequencing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059386" MajorTopicYN="N">Reverse Genetics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation & purification</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">Bats</Keyword><Keyword MajorTopicYN="Y">Emerging and re-emerging virus</Keyword><Keyword MajorTopicYN="Y">SARS-like coronavirus</Keyword><Keyword MajorTopicYN="Y">Severe acute respiratory syndrome coronavirus</Keyword><Keyword MajorTopicYN="Y">Zoonotic virus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2016</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>10</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2016</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">27644155</ArticleId><ArticleId IdType="doi">10.1080/21645515.2016.1228500</ArticleId><ArticleId IdType="pmc">PMC5287300</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2430-5</Citation><ArticleIdList><ArticleId IdType="pubmed">15695582</ArticleId></ArticleIdList></Reference><Reference><Citation>Bioessays. 2013 May;35(5):436-42</Citation><ArticleIdList><ArticleId IdType="pubmed">23450659</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):3048-53</Citation><ArticleIdList><ArticleId IdType="pubmed">26976607</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Pulm Med. 2014 May;20(3):233-41</Citation><ArticleIdList><ArticleId IdType="pubmed">24626235</ArticleId></ArticleIdList></Reference><Reference><Citation>Rev Med Virol. 2012 Jan;22(1):2-17</Citation><ArticleIdList><ArticleId IdType="pubmed">21905149</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Microbiol. 2016 Jun;24(6):490-502</Citation><ArticleIdList><ArticleId IdType="pubmed">27012512</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2014 Oct 2;514(7520):47-53</Citation><ArticleIdList><ArticleId IdType="pubmed">25171469</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5</Citation><ArticleIdList><ArticleId IdType="pubmed">16169905</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2014 Jan;101:105-12</Citation><ArticleIdList><ArticleId IdType="pubmed">24269477</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2005 Oct 28;310(5748):676-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16195424</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2016 Jun 03;13:87</Citation><ArticleIdList><ArticleId IdType="pubmed">27255185</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2016 Jun 21;44(6):1379-91</Citation><ArticleIdList><ArticleId IdType="pubmed">27287409</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Drug Discov. 2016 May;15(5):327-47</Citation><ArticleIdList><ArticleId IdType="pubmed">26868298</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2016 Aug;14 (8):523-34</Citation><ArticleIdList><ArticleId IdType="pubmed">27344959</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Rev Microbiol. 2009 Mar;7(3):226-36</Citation><ArticleIdList><ArticleId IdType="pubmed">19198616</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2012;7(11):e50366</Citation><ArticleIdList><ArticleId IdType="pubmed">23185609</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Feb;82(4):1899-907</Citation><ArticleIdList><ArticleId IdType="pubmed">18077725</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2005 Sep;79(18):11892-900</Citation><ArticleIdList><ArticleId IdType="pubmed">16140765</ArticleId></ArticleIdList></Reference><Reference><Citation>Virus Res. 2014 Aug 30;189:262-70</Citation><ArticleIdList><ArticleId IdType="pubmed">24930446</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2015 Mar;115:9-16</Citation><ArticleIdList><ArticleId IdType="pubmed">25542975</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2013 Nov 28;503(7477):535-8</Citation><ArticleIdList><ArticleId IdType="pubmed">24172901</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2015 Dec;21(12):1508-13</Citation><ArticleIdList><ArticleId IdType="pubmed">26552008</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2003 Oct 10;302(5643):276-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12958366</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Chem. 2016 Apr 22;291(17 ):9218-32</Citation><ArticleIdList><ArticleId IdType="pubmed">26953343</ArticleId></ArticleIdList></Reference><Reference><Citation>Antiviral Res. 2014 Jan;101:45-56</Citation><ArticleIdList><ArticleId IdType="pubmed">24184128</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1993 Nov 18;329(21):1524-30</Citation><ArticleIdList><ArticleId IdType="pubmed">8413475</ArticleId></ArticleIdList></Reference><Reference><Citation>Curr Opin Virol. 2012 Feb;2(1):63-77</Citation><ArticleIdList><ArticleId IdType="pubmed">22440968</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2014 Jul 14;9(7):e102415</Citation><ArticleIdList><ArticleId IdType="pubmed">25019613</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2004 Dec;10(12 Suppl):S88-97</Citation><ArticleIdList><ArticleId IdType="pubmed">15577937</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C11 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000C11 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:27644155
|texte= Understanding bat SARS-like coronaviruses for the preparation of future coronavirus outbreaks - Implications for coronavirus vaccine development.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:27644155" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |